ZAQS.ORG

34-year-old spent $16K to start a side hustle, built it 20 minutes at a time—now her business brings in up to $90K a month

9 hours ago

JPMorgan concedes it closed Trump's accounts after Jan. 6 attack on the Capitol

7 hours ago

Chaos, confusion and $200 billion dreams: What I saw at India's AI summit

19 hours ago

Trump to hike global tariffs to 15% from 10%, 'effective immediately'

9 hours ago

France's Macron says U.S. Supreme Court tariff ruling shows it's good to havecounterweights to power

13 hours ago

Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

2 days ago

Kennedy defends Trump glyphosate order as MAHA erupts

2 days ago

Danaher is tapping the M&A well yet again. But we might have had enough

4 days ago

French prosecutors investigate Nestle, Danone over contaminated baby formula

4 days ago

Novo Nordisk faces a defining year in the obesity drug market

5 days ago

How largest health-care education company in U.S. is tackling growing jobs gap

10 days ago

Novo CEO sees 15 million patient opportunity in Medicare obesity coverage

10 days ago

Moderna says FDA refuses to review its application for experimental flu shot

11 days ago

CVS tops quarterly estimates, reaffirms profit outlook as turnaround takes hold

11 days ago

Florida law models what genetic disease testing could be

11 days ago

FDA says Novo Nordisk's TV ad for obesity pill includes misleading claims

11 days ago

Novo Nordisk sues Hims & Hers over copycat versions of Wegovy pill, injections

12 days ago

Hims & Hers stops offering weight loss pill after threats of legal action

12 days ago

Healthy Returns: Pfizer execs chart out obesity drug strategy

14 days ago

White House launches direct-to-consumer drug site TrumpRx. Here's what to know

16 days ago

Eli Lilly sees GLP-1 growth accelerating as Novo Nordisk braces for a decline

16 days ago

Eli Lilly blows past quarterly estimates, posts strong outlook as GLP-1 sales soar

17 days ago

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

18 days ago

Pfizer beats quarterly estimates despite Covid product decline, reaffirms outlook

18 days ago

Merck tops quarterly estimates, posts modest outlook as generic competition looms

18 days ago

Eli Lilly CEO: Medicare coverage of obesity drugs could support pill launch

18 days ago

Eli Lilly plans $3.5 billion Pennsylvania manufacturing plant for obesity drugs

22 days ago

As ACA subsidies expire, health costs emerge as top economic worry for voters: survey

22 days ago

Breakthrough drug helps 11-year-old battle rare neurological gene mutation

22 days ago

Healthy Returns: 15 drugs added to Medicare price negotiations

22 days ago

Danaher stock fails to rise on solid earnings — leading us to question what's next

24 days ago

UnitedHealth posts earnings beat, soft revenue guidance as insurer plots turnaround

24 days ago

Next up in weight loss drugs: More pills, easier access and drug combinations

25 days ago

Healthy Returns: Structure Therapeutics CEO on obesity pills, future of GLP-1s

29 days ago

Amazon launches AI health-care tool for One Medical members

1 month ago

OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 billion

1 month ago